Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun 24;59(7):1190.
doi: 10.3390/medicina59071190.

Hypermagnesemia in Clinical Practice

Affiliations
Review

Hypermagnesemia in Clinical Practice

Aya Hasan Aal-Hamad et al. Medicina (Kaunas). .

Abstract

Hypermagnesemia is a relatively uncommon but potentially life-threatening electrolyte disturbance characterized by elevated magnesium concentrations in the blood. Magnesium is a crucial mineral involved in various physiological functions, such as neuromuscular conduction, cardiac excitability, vasomotor tone, insulin metabolism, and muscular contraction. Hypomagnesemia is a prevalent electrolyte disturbance that can lead to several neuromuscular, cardiac, or nervous system disorders. Hypermagnesemia has been associated with adverse clinical outcomes, particularly in hospitalized patients. Prompt identification and management of hypermagnesemia are crucial to prevent complications, such as respiratory and cardiovascular negative outcomes, neuromuscular dysfunction, and coma. Preventing hypermagnesemia is crucial, particularly in high-risk populations, such as patients with impaired renal function or those receiving magnesium-containing medications or supplements. Clinical management of hypermagnesemia involves discontinuing magnesium-containing therapies, intravenous fluid therapy, or dialysis in severe cases. Furthermore, healthcare providers should monitor serum magnesium concentration in patients at risk of hypermagnesemia and promptly intervene if the concentration exceeds the normal range.

Keywords: clinical practice; electrolyte disturbance; hypermagnesemia; hypomagnesemia; magnesium homeostasis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Epithelial magnesium transport in the intestine and kidney. The figure demonstrates the transcellular and paracellular mechanisms of Mg transportation. TRPM6/7: transient receptor potential melastatin cation channels 6 and 7.
Figure 2
Figure 2
Clinical manifestation of hypermagnesemia. CNS: central nervous system; CVS: cardiovascular system; GI: gastrointestinal system; MSK: musculoskeletal.
Figure 3
Figure 3
Management of hypermagnesemia according to Mg concentration.

Similar articles

Cited by

References

    1. Al Alawi A.M., Majoni S.W., Falhammar H. Magnesium and Human Health: Perspectives and Research Directions. Int. J. Endocrinol. 2018;2018:9041694. doi: 10.1155/2018/9041694. - DOI - PMC - PubMed
    1. Gröber U., Schmidt J., Kisters K. Magnesium in Prevention and Therapy. Nutrients. 2015;7:8199–8226. doi: 10.3390/nu7095388. - DOI - PMC - PubMed
    1. Al Alawi A.M., Berhane T., Majoni S.W., Falhammar H. Characteristics and health outcomes of patients hospitalised with hypomagnesaemia: A retrospective study from a single centre in the Northern Territory of Australia. Intern. Med. J. 2022;52:1544–1553. doi: 10.1111/imj.15442. - DOI - PubMed
    1. Cheungpasitporn W., Thongprayoon C., Qian Q. Dysmagnesemia in Hospitalized Patients: Prevalence and Prognostic Importance. Mayo Clin. Proc. 2015;90:1001–1010. doi: 10.1016/j.mayocp.2015.04.023. - DOI - PubMed
    1. Sontia B., Touyz R.M. Role of magnesium in hypertension. Arch. Biochem. Biophys. 2007;458:33–39. doi: 10.1016/j.abb.2006.05.005. - DOI - PubMed